共 25 条
- [1] Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 713 - 720
- [2] Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08): : 595 - 604
- [3] Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (01): : 17 - 26
- [5] Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial [J]. Diabetologia, 2016, 59 : 2561 - 2571
- [6] Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (01): : 213 - 222
- [8] Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1110 - 1119